Sami Corwin
Stock Analyst at William Blair
(4.68)
# 803
Out of 5,023 analysts
440
Total ratings
50.5%
Success rate
14.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Rated: Hold | n/a | $1.81 | - | 1 | Sep 23, 2026 | |
| LEGN Legend Biotech | Rated: Hold | n/a | $18.57 | - | 19 | Sep 23, 2026 | |
| NKTX Nkarta | Rated: Hold | n/a | $2.58 | - | 16 | Sep 23, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | n/a | $2.56 | - | 24 | Sep 23, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | n/a | $15.22 | - | 15 | Sep 18, 2026 | |
| OBX Obsidian Therapeutics | Initiated Coverage: Buy | $43 | $13.59 | +216.41% | 1 | Sep 9, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $20.43 | - | 12 | Sep 9, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | n/a | $24.50 | - | 31 | Sep 8, 2026 | |
| QURE uniQure | Initiated Coverage: Buy | $73 | $23.46 | +211.17% | 30 | Sep 2, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | n/a | $57.18 | - | 15 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $55.43 | - | 21 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.50 | - | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.00 | - | 28 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.22 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.65 | - | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.85 | - | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.5641 | - | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.99 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $322.28 | - | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $18.52 | +1.24% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.50 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.46 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.53 | n/a | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.08 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.63 | n/a | 4 | Feb 1, 2023 |
Alector
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $1.81
Upside: -
Legend Biotech
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $18.57
Upside: -
Nkarta
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $2.58
Upside: -
Rocket Pharmaceuticals
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $2.56
Upside: -
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.22
Upside: -
Obsidian Therapeutics
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $13.59
Upside: +216.41%
Tyra Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.43
Upside: -
Beam Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.50
Upside: -
uniQure
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $23.46
Upside: +211.17%
BioMarin Pharmaceutical
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $57.18
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.43
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.50
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.00
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.22
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.65
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.85
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.5641
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.99
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $322.28
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $18.52
Upside: +1.24%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.50
Upside: -
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.46
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $14.08
Upside: n/a
Feb 1, 2023
Reiterated: Buy
Price Target: n/a
Current: $4.63
Upside: n/a